KORU Medical Systems Inc (KRMD)

NASDAQ
Currency in USD
2.950
-0.110(-3.59%)
Closed·
After Hours
2.9500.000(0.00%)
·
KRMD Scorecard
Full Analysis
2 analysts have revised their earnings upwards for the upcoming period
KRMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.9503.149
52 wk Range
1.8605.050
Key Statistics
Edit
Prev. Close
2.95
Open
3.06
Day's Range
2.95-3.149
52 wk Range
1.86-5.05
Volume
82.93K
Average Volume (3m)
159.62K
1-Year Change
29.39%
Book Value / Share
0.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KRMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.500
Upside
+86.44%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

KORU Medical Systems Inc Company Profile

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

KORU Medical Systems Inc Earnings Call Summary for Q1/2025

  • Q1 2025 revenue of $9.6M beat forecasts by 9.3%, up 18% YoY; stock rose 1.1% in aftermarket trading
  • Full-year revenue guidance raised to $38.5M-$39.5M; company targets sustainable 20%+ growth
  • Domestic core revenue up 16%, international core revenue up 36%; gross margin improved 50 bps to 62.8%
  • Strategic focus on international expansion, new drug opportunities, and maintaining 61-63% gross margin
  • Company maintains strong position in SCIG market, supporting 45,000 chronic patients worldwide
Last Updated: 2025/05/07, 23:44
Read Full Transcript

Compare KRMD to Peers and Sector

Metrics to compare
KRMD
Peers
Sector
Relationship
P/E Ratio
−25.7x−3.0x−0.5x
PEG Ratio
−0.42−0.070.00
Price/Book
8.3x2.5x2.6x
Price / LTM Sales
3.9x2.9x3.0x
Upside (Analyst Target)
103.4%50.6%54.1%
Fair Value Upside
Unlock5.0%8.7%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5.500
(+86.44% Upside)

Earnings

Latest Release
May 07, 2025
EPS / Forecast
-- / -0.03
Revenue / Forecast
9.60M / 8.79M
EPS Revisions
Last 90 days

FAQ

What Is the KORU Medical Systems (KRMD) Stock Price Today?

The KORU Medical Systems stock price today is 2.95

What Stock Exchange Does KORU Medical Systems Trade On?

KORU Medical Systems is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for KORU Medical Systems?

The stock symbol for KORU Medical Systems is "KRMD."

What Is the KORU Medical Systems Market Cap?

As of today, KORU Medical Systems market cap is 136.12M.

What Is KORU Medical Systems's Earnings Per Share (TTM)?

The KORU Medical Systems EPS (TTM) is -0.12.

When Is the Next KORU Medical Systems Earnings Date?

KORU Medical Systems will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is KRMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.